TX-001HR is associated with a clinically meaningful effect on severity of moderate to severe vasomotor symptoms in the REPLENISH trial

OBJECTIVE: The aim of the study was to evaluate the clinically meaningful effect of oral TX-001HR (17β-estradiol [E2]/progesterone [P4]) capsules on hot flushes severity (vasomotor symptoms [VMS] severity scale) using the patient-reported Clinical Global Impression (CGI). METHODS: REPLENISH (NCT0194...

Descripción completa

Detalles Bibliográficos
Autores principales: Constantine, Ginger D., Simon, James A., Kaunitz, Andrew M., Pickar, James H., Revicki, Dennis A., Graham, Shelli, Bernick, Brian, Mirkin, Sebastian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
Original Studies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7587237/
https://www.ncbi.nlm.nih.gov/pubmed/33110039
http://dx.doi.org/10.1097/GME.0000000000001602

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7587237/
https://www.ncbi.nlm.nih.gov/pubmed/33110039
http://dx.doi.org/10.1097/GME.0000000000001602

Ejemplares similares